Adam C. Berger, MD, FACS
- Chief, Melanoma and Soft Tissue Surgical Oncology
- Associate Director for Shared Resources
As Chief of Melanoma for the multidisciplinary Melanoma and Soft Tissue Surgical Oncology Program at the Rutgers Cancer Institute of New Jersey and Professor of Surgery at Rutgers Robert Wood Johnson Medical School, I work closely with my colleagues to provide the most advanced treatment options including immunotherapy, precision medicine, clinical trials, and complex surgical procedures. I have been in practice as a surgical oncologist for the past 15 years with a specialty in melanoma and other complex cutaneous oncological malignancies such as Merkel Cell carcinoma, locally advanced basal cell and squamous cell carcinomas, and eccrine carcinoma. As a surgical oncologist, I know the importance of the multidisciplinary care of patients with skin cancers and soft tissue sarcomas.
Prior to arriving at Rutgers, I was the Chief of the Section of Surgical Oncology at Thomas Jefferson University in Philadelphia from 2004 to July of 2019 where my clinical practice consisted primarily of patients with melanoma and breast cancer. I was voted a Top Doc in Philadelphia for the past four years.
In addition to a passion for taking care of patients with cutaneous and soft tissue oncologic issues, I have a passion for clinical research. I have been very active in both clinical outcomes research as well as an investigator for numerous cancer clinical trials including adjuvant immunotherapy and vaccine trials for patients with advanced stage melanoma. I have been a co-investigator for several national, multi-center clinical trials in melanoma, breast cancer, and GI malignancies. I am a member of the Melanoma and Surgery Committees of the Eastern Cooperative Oncology Group (ECOG), one of the large, national cooperative groups which run multi-institution cancer clinical trials.
I received my undergraduate education at The University of Chicago with an Honors degree in History, Philosophy and Social Studies of Science and Medicine. I went on to Medical School at New York University and completed my General Surgery Residency at the University of Maryland. During my residency, I completed my Surgical Oncology Fellowship at the Fox Chase Cancer Center in 2004. During my residency, I spent two years as a Clinical and Research Fellow in the Surgery Branch of the National Cancer Institute. It was while at the NCI that I met two of my most important mentors and current colleagues in Surgical Oncology—Drs. Richard Alexander and Steven Libutti.
This is an exciting time in the treatment of patients with melanoma and soft tissue sarcoma because there are so many new therapies available for patients with both metastatic and earlier stage disease. More than ever, we are now able to target therapies in a more personalized manner to better treat these two diseases and improve outcomes.
June 29, 2023
Doctor was very clear about the surgery.
June 1, 2023
I felt I was in good hands!
February 23, 2023
He listened to my questions and gave very reassuring answers. He inspired confidence and dispelled a lot of my fears.
February 22, 2023
Experience good! All test results were OK & exam satisfactory & 3 month appointment set.
January 23, 2023
Good. Very caring & informative.
January 10, 2023
Very good excellent service and very knowledgeable doctor. Great contact with patient.
December 16, 2022
*Dr. Berger along w/his full team were very professional & answered & cared about all my questions.
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.
Frequently Asked Questions on Staying Safe in the Sun
According to the American Cancer Society, each year, more than 5.4 million basal cell and squamous cell skin cancers, which are the most common and are often related to sun exposure, are diagnosed in the United States. While skin cancer can be detrimental, it is also highly preventable. Read more
Adam C. Berger, MD, FACS, chief of Melanoma and Soft Tissue Surgical Oncology and associate director for Shared Resources at Rutgers Cancer Institute of New Jersey addresses common questions. Read more